11:11 CET
PS3 - Pre-Congress Symposium 3 - Radiopharmacy + Oncology & Theranostics + Dosimetry Committee: Alpha Therapy - Practical Aspects on Chemistry and Applications
Saturday, October 12, 09:00 - 12:00
Type of session: Pre-Congress Symposium
Chairpersons: F. Buchertseifer (Karlsruhe/DE), E. Ocak (Istanbul/TR)

PS-18
09:00
An Overview of Production and Radiochemistry of Alpha-Emitting Radionuclides
F. Bruchertseifer;
Europäische Kommission, Institut für Transurane, Nuklearchemie, Karlsruhe, GERMANY.
PS-19
09:25
Safe Handling of Alpha-Emitting Radionuclides During Preparation and Application of Radiopharmaceuticals
S. Holm;
Klinik for Klinisk Fysiologi, Nuklearmedicin & PET, Copenhagen, DENMARK.
PS-20
09:50
Stability of Alpha-Emitting Radiopharmaceuticals - Impact on TATs
M. Benesova;
German Cancer Research Center, Heidelberg, GERMANY.
PS-21
10:15
COFFEE BREAK
D. Discussion;
1
PS-22
10:45
Recoil Effect and its Impact on TATs Dosimetry
N. Chouin;
French Institute of Health and Medical Research, Nantes, FRANCE.
PS-23
11:05
Antibody Derivatives as a Vehicle for TAT - Advantages, Disadvantages, Future Prospects
S. Heskamp;
Radboud Institute for Molecular Life Sciences, Nijmegen, NETHERLANDS.
PS-24
11:25
Future Directions for Targeted Alpha Therapy Beyond Prostate Cancer
M. Miederer;
Department of Nuclear Medicine, University Medical Center Mainz, Mainz, GERMANY.
PS-25
11:45
Discussion
D. Discussion;
1
This website uses cookies. Learn more